About Pluton Biosciences
Pluton Biosciences is a private company based in St. Louis, Missouri. It has reported $24,262,039 raised in three offerings on Form D since January 2019. Its chief executive is Elizabeth Gallegos.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2023 | Jun 2, 2023 | $17,579,071fully sold | 12 | $1.4M | EquityRule 506(b) | Form D ↗ |
| Sep 17, 2021 | Oct 1, 2021 | $6,682,968fully sold | 38 | $175K | EquityRule 506(b) | Form D ↗ |
| Not yet | Jan 2, 2019 | $0of $1.0M target | 0 | — | Debt, Options, Securities on exerciseRule 506(c) | Form D ↗ |
| Total, three offerings | $24,262,039 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pluton Biosciences's Form D filed Jun 2, 2023.
Earlier filings also listed Wesley Selke (director, last listed Oct 2021), Steven Slater (executive officer and director, last listed Oct 2021), Glendon Schuster (director, last listed Oct 2021), Charles Walch (executive officer, last listed Oct 2021) and Charlie Walch (executive officer and director, last listed Jan 2019).